Cargando…

EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells

Background: Ovarian cancer is a fatal malignant gynecological tumor. Ovarian cancer stem cells (OCSCs) contribute to resistance to chemotherapy. The polycomb group protein enhancer of zeste homolog 2 (EZH2) plays a key role in maintaining CSCs. Here, we aimed to investigate the specific mechanism by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wen, Yiping, Hou, Yaya, Yi, Xiaoqing, Sun, Si, Guo, Jing, He, Xiaoqi, Li, Tao, Cai, Jing, Wang, Zehua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778604/ https://www.ncbi.nlm.nih.gov/pubmed/33408782 http://dx.doi.org/10.7150/thno.48101

Ejemplares similares

SOX2 is required to maintain cancer stem cells in ovarian cancer
por: Wen, Yiping, et al.
Publicado: (2017)

Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target
por: Wen, Yiping, et al.
Publicado: (2017)

EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
por: Yi, Xiaoqing, et al.
Publicado: (2017)

EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer
por: Sun, Si, et al.
Publicado: (2020)

EZH2-miRNA Positive Feedback Promotes Tumor Growth in Ovarian Cancer
por: Liu, Ting, et al.
Publicado: (2021)

Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancer
por: KUANG, YAN, et al.
Publicado: (2013)

Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
por: Li, Shan-Shan, et al.
Publicado: (2018)

c-Myc maintains the self-renewal and chemoresistance properties of colon cancer stem cells
por: Zhang, Huan-Le, et al.
Publicado: (2019)

Exosomes in ovarian cancer ascites promote epithelial–mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p
por: Cai, Jing, et al.
Publicado: (2021)

Involvement of Cancer Stem Cells in Chemoresistant Relapse of Epithelial Ovarian Cancer Identified by Transcriptome Analysis
por: Sun, Yaoqi, et al.
Publicado: (2022)

TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis
por: Nuti, Sudhakar V., et al.
Publicado: (2014)

Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer
por: Li, Xin, et al.
Publicado: (2021)

Morphine promotes cancer stem cell properties, contributing to chemoresistance in breast cancer
por: Niu, Dong-Ge, et al.
Publicado: (2015)

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
por: Deng, Junli, et al.
Publicado: (2016)

Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
por: Hu, L, et al.
Publicado: (2010)

Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer
por: Nair, Jayakumar, et al.
Publicado: (2020)

The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
por: Zhu, Xiaolin, et al.
Publicado: (2021)

Tumor evolution and chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Adipocytes promote ovarian cancer chemoresistance
por: Yang, Jiang, et al.
Publicado: (2019)

Ezh1 Targets Bivalent Genes to Maintain Self-Renewing Stem Cells in Ezh2-Insufficient Myelodysplastic Syndrome
por: Aoyama, Kazumasa, et al.
Publicado: (2018)

PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR/CHK1 signaling in gastric cancer
por: Huang, Weicai, et al.
Publicado: (2022)

4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
por: Nie, Sipei, et al.
Publicado: (2021)

Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis
por: Li, Zhang, et al.
Publicado: (2021)

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
por: Roy, Lynn, et al.
Publicado: (2018)

DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHKα to disrupt choline metabolism
por: Li, Zhenzhen, et al.
Publicado: (2022)

Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers
por: YING, HUANCHUN, et al.
Publicado: (2015)

SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression
por: Zhang, Zhijie, et al.
Publicado: (2020)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
por: Emmings, Edith, et al.
Publicado: (2019)

Chemoresistance and targeted therapies in ovarian and endometrial cancers
por: Brasseur, Kevin, et al.
Publicado: (2016)

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Dar, Sajad, et al.
Publicado: (2017)

Bevacizumab as adjunct to chemotherapy for chemoresistant ovarian cancer
por: Hamilton, Gerhard
Publicado: (2020)

Autophagy maintains the stemness of ovarian cancer stem cells by FOXA2.
por: Peng, Qiaohua, et al.
Publicado: (2017)

CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic Properties
por: Zhu, Shudong, et al.
Publicado: (2021)

SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells
por: Yue, Yongfang, et al.
Publicado: (2020)

Chk1, Chk2, is the amplifier on?
por: Dove, Alan W.
Publicado: (2001)

Dicer affects cisplatin-mediated apoptosis in epithelial ovarian cancer cells
por: Wang, Xi, et al.
Publicado: (2018)

Chemoresistance and the Self-Maintaining Tumor Microenvironment
por: Yeldag, Gulcen, et al.
Publicado: (2018)

Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer
por: Meyer, Felix, et al.
Publicado: (2020)

Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance
por: Ramadoss, S, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8b597808rd6ogp19nrk4hn5615